Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04479241 |
|---|---|
| Brief Title: | LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma |
| First Submitted : | July 16, 2020 |
| First Submitted that Met QC Criteria : | July 16, 2020 |
| First Posted : | July 21, 2020 |
| Last Update Submitted that Met QC Criteria : | September 26, 2023 |
| Last Update Posted : | September 28, 2023 |